Lutetium 177 Market Size, Share and Trends Report 2025 to 2034

Report Id: 3024 Pages: 180 Last Updated: 18 December 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Lutetium-177 Market -

Lutetium-177 Market by Application-

  • Oncology
    • mCRPC
    • NETs
    • RCC
    • Other Cancers
  • Non-Oncology
    • Arthritis
    • Other

Lutetium-177 Market

Lutetium-177 Market by Type-

  • Carrier-Added Lutetium-177
  • No-Carrier-Added Lutetium-177

 Lutetium-177 Market by Product Type-

  • Approved Drugs
    • Pluvicto (Pro)
    • Lutathera (Pro)
  • Pipeline Drugs
  • Investigational Drugs

Lutetium-177 Market by Scale of Operation-

  • Preclinical
  • Clinical
  • Commercial

Lutetium-177 Market by End-user-

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Research Institutions/CROs

Lutetium-177 Market by Production-

  • Reactor-Based
  • Cyclotron-Based

Lutetium-177 Market by Technology-

  • Targeting Ligands
  • Production Innovations
  • Combination Therapies

Lutetium-177 Market by Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Lutetium-177 Market Snapshot

Chapter 4. Global Lutetium-177 Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Lutetium-177 Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Radiopharma Industry Trends

Chapter 5. Lutetium-177 Market Segmentation 1: By Application, Estimates & Trend Analysis
5.1. Market Share by Application, 2023 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Application:

5.2.1. Oncology

5.2.1.1. mCRPC
5.2.1.2. NETs
5.2.1.3. RCC
5.2.1.4. Other Cancers

5.2.2. Non-Oncology

5.2.2.1. Arthritis
5.2.2.2. Other

Chapter 6. Lutetium-177 Market Segmentation 2: By Type, Estimates & Trend Analysis
6.1. Market Share by Type, 2023 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Type:

6.2.1. Carrier-Added Lutetium-177
6.2.2. No-Carrier-Added Lutetium-177

Chapter 7. Lutetium-177 Market Segmentation 3: By Product Type, Estimates & Trend Analysis
7.1. Market Share by Product Type 2023 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Product Type:

7.2.1. Approved Drugs

7.2.1.1. Pluvicto (Pro)
7.2.1.2. Lutathera (Pro)

7.2.2. Pipeline Drugs
7.2.3. Investigational Drug

Chapter 8. Lutetium-177 Market Segmentation 4: By Scale of Operation, Estimates & Trend Analysis
8.1. Market Share by Scale of Operation, 2023 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Scale of Operation:

8.2.1. Preclinical
8.2.2. Clinical
8.2.3. Commercial

Chapter 9. Lutetium-177 Market Segmentation 5: By End-user, Estimates & Trend Analysis
9.1. Market Share by End-user, 2023 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following End-user:

9.2.1. Hospitals & Clinics
9.2.2. Pharmaceutical & Biotechnology Companies
9.2.3. Research Institutions/CROs

Chapter 10. Lutetium-177 Market Segmentation 6: By Production, Estimates & Trend Analysis
10.1. Market Share by Production, 2023 & 2034
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Production:

10.2.1. Reactor-Based
10.2.2. Cyclotron-Based

Chapter 11. Lutetium-177 Market Segmentation 7: By Technology, Estimates & Trend Analysis
11.1. Market Share by Technology, 2023 & 2034
11.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Technology:

11.2.1. Targeting Ligands
11.2.2. Production Innovations
11.2.3. Combination Therapies

Chapter 12. Lutetium-177 Market Segmentation 8: Regional Estimates & Trend Analysis
12.1. Global Lutetium-177 Market, Regional Snapshot 2023 & 2034
12.2. North America

12.2.1. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

12.2.1.1. US
12.2.1.2. Canada

12.2.2. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
12.2.3. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
12.2.4. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Product Type 2021-2034
12.2.5. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
12.2.6. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
12.2.7. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Production, 2021-2034
12.2.8. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034

12.3. Europe

12.3.1. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

12.3.1.1. Denmark
12.3.1.2. Finland
12.3.1.3. Austria
12.3.1.4. France
12.3.1.5. Germany
12.3.1.6. Israel
12.3.1.7. Italy
12.3.1.8. Netherlands
12.3.1.9. Norway
12.3.1.10. Poland

12.3.2. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
12.3.3. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
12.3.4. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Product Type 2021-2034
12.3.5. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
12.3.6. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
12.3.7. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Production, 2021-2034
12.3.8. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts Technology, 2021-2034

12.4. Asia Pacific

12.4.1. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

12.4.1.1. Australia
12.4.1.2. China
12.4.1.3. India
12.4.1.4. Indonesia
12.4.1.5. Japan
12.4.1.6. Malaysia
12.4.1.7. Philippines
12.4.1.8. Singapore
12.4.1.9. South Korea
12.4.1.10. Taiwan
12.4.1.11. Thailand
12.4.1.12. Rest of APAC

12.4.2. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
12.4.3. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
12.4.4. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts By Product Type 2021-2034
12.4.5. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
12.4.6. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
12.4.7. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Production, 2021-2034
12.4.8. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034

12.5. Latin America

12.5.1. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

12.5.1.1. Argentina
12.5.1.2. Brazil
12.5.1.3. Mexico
12.5.1.4. Rest of LATAM

12.5.2. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
12.5.3. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
12.5.4. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Product Type 2021-2034
12.5.5. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
12.5.6. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
12.5.7. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Production, 2021-2034
12.5.8. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034

12.6. Middle East & Africa

12.6.1. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

12.6.1.1. Egypt
12.6.1.2. Israel
12.6.1.3. Nigeria
12.6.1.4. Saudi Arabia
12.6.1.5. Qatar
12.6.1.6. United Arab Emirates
12.6.1.7. Rest of MEA

12.6.2. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
12.6.3. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
12.6.4. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Product Type 2021-2034
12.6.5. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
12.6.6. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
12.6.7. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Production, 2021-2034
12.6.8. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034

Chapter 13. Competitive Landscape
13.1. Major Mergers and Acquisitions/Strategic Alliances
13.2. Company Profiles


13.2.1. Novartis AG

13.2.1.1. Business Overview
13.2.1.2. Key Product/Service
13.2.1.3. Financial Performance
13.2.1.4. Modeance
13.2.1.5. Geographical Presence
13.2.1.6. Recent Developments with Business Strategy

13.2.2. Curium
13.2.3. Telix Pharmaceuticals
13.2.4. ITM Isotope Technologies
13.2.5. Eli Lilly (via POINT Biopharma)
13.2.6. Radiopharm Theranostics
13.2.7. Advanced Accelerator Applications (AAA)
13.2.8. Evergreen Theragnostics
13.2.9. Nusano Inc.
13.2.10. Nordic Nanovector

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
9951
Security Code field cannot be blank!

Frequently Asked Questions

Lutetium-177 Market Size is valued at USD 2.11 Bn in 2024 and is predicted to reach USD 7.41 Bn by the year 2034

Lutetium-177 Market is expected to grow at a 11.6% CAGR during the forecast period for 2025 to 2034.

Novartis AG, Curium, Telix Pharmaceuticals, ITM Isotope Technologies, Eli Lilly (via POINT Biopharma), Radiopharm Theranostics, Advanced Accelerator A

Application, Type, Product Type, Scale of Operation, End User, Production and Technology are the key segments of the Lutetium-177 Market.

North America region is leading the Lutetium-177 Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying